Article

A novel imaging ligand as a biomarker for mutant huntingtin-lowering in Huntington’s…

medRxiv · 2021 · Bertoglio, D.; Bard, J.; Hessmann, M.; Liu, L.; Gaertner, A.; De Lombaerde, S.; Huscher, B.; Zajicek, F.; Miranda, A.; Peters, F.; Herrmann, F.; Schaertl, S.; Vasilkovska, T.; Brown, C. J.; Johnson, P. D.; Prime, M. E.; Mills, M. R.; Van der Linden, A.; Mrzljak, L.; Khetarpal, V.; Wang, Y.; Marchionini, D. M.; Skinbjerg, M.; Verhaeghe, J.; Dominguez, C.; Staelens, S.; Munoz-Sanjuan, I.

Key facts

Title A novel imaging ligand as a biomarker for mutant huntingtin-lowering in Huntington’s disease
First author Bertoglio, D.; Bard, J.; Hessmann, M.; Liu, L.; Gaertner, A.; De Lombaerde, S.; Huscher, B.; Zajicek, F.; Miranda, A.; Peters, F.; Herrmann, F.; Schaertl, S.; Vasilkovska, T.; Brown, C. J.; Johnson, P. D.; Prime, M. E.; Mills, M. R.; Van der Linden, A.; Mrzljak, L.; Khetarpal, V.; Wang, Y.; Marchionini, D. M.; Skinbjerg, M.; Verhaeghe, J.; Dominguez, C.; Staelens, S.; Munoz-Sanjuan, I.
Journal medRxiv
Published Jul 11, 2021
DOI 10.1101/2021.07.09.451725
Devices mentioned K042152, K062324, K143583, K940422, K982100, K982382
Product codes mentioned CEK, DEW, FPB, GIA, JCJ, CFN, DFZ, MHX

At a glance

  • 1–9 FDA submissions mentioned
  • 1–9 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature